Bringing down the ROS: a new therapeutic approach for PPHN.
Firth
Amy L
AL
Yuan
Jason X-J
JX
D001708:Biopterins / Q000031:analogs & derivatives / Q000378:metabolism; D015199:Extracorporeal Membrane Oxygenation; D006801:Humans; D007231:Infant, Newborn; D008168:Lung / Q000098:blood supply / Q000378:metabolism; D009569:Nitric Oxide / Q000096:biosynthesis*; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D010547:Persistent Fetal Circulation Syndrome / Q000453:epidemiology / Q000378:metabolism* / Q000628:therapy*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D013482:Superoxide Dismutase / Q000378:metabolism / Q000627:therapeutic use; D014664:Vasodilation / Q000187:drug effects
D017382:Reactive Oxygen Species; D001708:Biopterins; D009569:Nitric Oxide; C496314:NOS3 protein, human; D052250:Nitric Oxide Synthase Type III; D013482:Superoxide Dismutase; C003402:sapropterin; D010100:Oxygen